Intermittent Liposomal Amphotericin B Primary Prophylaxis

Clinical trial NCT00451711 · UNKNOWN

Trial details

NCT number: NCT00451711
Sponsor: Bayside Health
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2007-05-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.